Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS
Clinical trial NCT06046313 · RECRUITING
Trial details
- NCT number
- NCT06046313
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2025-10-19
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.